| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/IJC.2910060207 |
| P698 | PubMed publication ID | 5479434 |
| P2093 | author name string | B Rosenberg | |
| H C Harder | |||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | platinum | Q880 |
| P1104 | number of pages | 10 | |
| P304 | page(s) | 207-216 | |
| P577 | publication date | 1970-09-01 | |
| P1433 | published in | International Journal of Cancer | Q332492 |
| P1476 | title | Inhibitory effects of anti-tumor platinum compounds on DNA, RNA and protein syntheses in mammalian cells in virtro | |
| P478 | volume | 6 |
| Q71879720 | 1,3‐Diphenylpropane‐1,3‐diamines, VI: DNA‐Interaction, Estrogen Receptor Affinity, and Cytostatic Activity of 1,3‐Diphenylpropane‐1,3‐diamine‐Pt(II) Complexes |
| Q67290762 | A Circular Dichroism Study of DNA . Platinum Complexes. Differentiation between Monofunctional. cis-Bidentate and trans-Bidentate Platinum Fixation on a Series of DNAs |
| Q40202099 | A crystalline platinum blue: its molecular structure, chemical reactivity, and possible relevance to the mode of action of antitumor platinum drugs |
| Q44770779 | A density functional reactivity theory (DFRT) based approach to understand the interaction of cisplatin analogues with protecting agents |
| Q39181502 | A platinum complex that binds non-covalently to DNA and induces cell death via a different mechanism than cisplatin |
| Q37905280 | A strategy for the development of two clinically active cisplatin analogs: CBDCA and CHIP. |
| Q52837598 | An Analysis of the Interaction of a Platinum Complex and Radiation with CHO Cells Using the Molecular Theory of Cell Survival |
| Q39496661 | Antineoplastic drugs: clinical pharmacology and therapeutic use. |
| Q40150996 | Antitumor activity of platinum complexes |
| Q36379523 | Base-pair substitution hotspots in GAG and GCG nucleotide sequences in Escherichia coli K-12 induced by cis-diamminedichloroplatinum (II). |
| Q41258864 | Bifunctional binding of cisplatin to DNA: why does cisplatin form 1,2-intrastrand cross-links with ag but not with GA? |
| Q33842478 | Binding of kinetically inert metal ions to RNA: the case of platinum(II). |
| Q38872477 | Biologically active [Pd2L4](4+) quadruply-stranded helicates: stability and cytotoxicity. |
| Q78237248 | Capillary electrophoretic study of cisplatin interaction with nucleoside monophosphates, di- and trinucleotides |
| Q68157850 | Changes in the cytoskeleton pattern of tumor cells by cisplatin in vitro |
| Q42463568 | Cis-diamminedichloroplatinum (II) ototoxicity in the guinea pig. |
| Q39718529 | Cis-diamminedichloroplatinum(II). A new antineoplastic agent derived from the group of heavy metal complexes (author's transl) |
| Q34196954 | Cis-platin ototoxicity in previously noise-exposed guinea pigs |
| Q50610869 | Cis-platinum: a new anticancer agent |
| Q36184105 | Cisplatin Targeting of Bacterial Ribosomal RNA Hairpins |
| Q40040349 | Cisplatin and siRNA interference with structure and function of Wnt-5a mRNA: design and in vitro evaluation of targeting AU-rich elements in the 3' UTR. |
| Q72336793 | Cisplatin induced nephrotoxicity and the modulating effect of glutathione ester |
| Q68921233 | Cisplatin nephrotoxicity |
| Q42343539 | Cisplatin-Induced Nephrotoxicity; Protective Supplements and Gender Differences |
| Q37380106 | Cisplatin: a review of toxicities and therapeutic applications |
| Q35938726 | Combined cis-platinum and alpha interferon therapy of advanced hepatocellular carcinoma |
| Q37729428 | Common Chemical Inductors of Replication Stress: Focus on Cell-Based Studies |
| Q59096780 | Cross-linking of Complementary Strands of DNA in Mammalian Cells by Antitumour Platinum Compounds |
| Q33998355 | Current status of the development of trans-platinum antitumor drugs |
| Q72597362 | Cytologic observations on the effects of metallocene dichlorides on human fibroblasts cultivated in vitro |
| Q67020074 | Cytotoxicity and influence on radiation dose response curve of cis-diamminedichloroplatinum II (cis-DDP) |
| Q67322647 | DNA-platinum interactions in vitro with trans- and cis- Pt(NH3)2Cl2 |
| Q71850691 | Differences in the inhibition of translation by cisplatin, transplatin, and certain related compounds |
| Q68877372 | Differential effects of cisplatin on mouse hepatic and renal mitochondrial DNA |
| Q41614336 | Differential effects of cisplatin on the expression of chimeric marker genes in CV-1 cells |
| Q48058684 | Direct measurement of interaction forces between a platinum dichloride complex and DNA molecules. |
| Q53884367 | Early morphological and chemical changes induced by cisplatin in the guinea pig organ of Corti. |
| Q71844106 | Effect of Dalton's lymphoma on the antigen presentation of murine peritoneal macrophages |
| Q40026912 | Effect of cis-platinum(II)diamminodichloride on cell division of Hyphomicrobium and Caulobacter |
| Q36767060 | Effect of cis-platinum(II)diamminodichloride on wild type and deoxyribonucleic acid repair deficient mutants of Escherichia coli |
| Q39977337 | Effect of pKM101 on cell killing and specificity of mutation induction by cis-diaminedichloroplatinum(II) in Escherichia coli K-12 |
| Q34662725 | Effect of platinum and palladium salts on thymidine incorporation into DNA of rat tissues |
| Q44479123 | Effect of serum on inhibition of DNA synthesis in leukemia cells by cis- and trans-(Pt (NH3) 2C1(2)). |
| Q59649953 | Effects of cobalt (III) complexes on growth and metabolism of Escherichia coli |
| Q69355172 | Effects of cobalt (III) complexes on the endogenous metabolism of Escherichia coli |
| Q67947463 | Effects of isomeric 2-(arylmethylamino)-1,3-propanediols (AMAPs) and clinically established agents on macromolecular synthesis in P388 and MCF-7 cells |
| Q53520548 | Elasticity of cisplatin-bound DNA reveals the degree of cisplatin binding. |
| Q43591020 | Evidence for lack of mitochondrial DNA repair following cis-dichlorodiammineplatinum treatment |
| Q58874510 | Experimental cisplatin neuronopathy in rats and the effect of retinoic acid administration |
| Q70369960 | Genotoxic effects of cisplatin in somatic tissue of Drosophila melanogaster |
| Q24629542 | Glutathione pathway genetic polymorphisms and lung cancer survival after platinum-based chemotherapy |
| Q33493799 | Haematological toxicity of carboplatin and cisplatin combined with whole body hyperthermia in rats |
| Q53028113 | In vitro studies on genotoxicity and cytotoxicity of the anticancer drugs cisplatin and cofplaton, a caffeine-8-ether plus cisplatinum compound |
| Q40504348 | Inactivation of Tetrahymena rRNA self-splicing by cis-platin proceeds through dissociable complexes |
| Q77486703 | Induction of instability of p34(cdc2) expression by treatment with cisplatin (CDDP) in mouse teratocarcinoma F9 cells |
| Q45820181 | Influence of cis-dichlorodiammineplatinum (II) on growth of SV 40 virus in green monkey kidney cells |
| Q41181434 | Influence of cisplatin on cell-cycle progression in xenografted human head and neck carcinomas |
| Q47341135 | Inhibition by caffeine of post-replication repair in Chinese hamster cells treated with cis platinum (II) diamminedichloride: The extent of platinum binding to template DNA in relation to the size of low molecular weight nascent DNA |
| Q69355321 | Inhibition of bacterial growth and nucleic acids synthesis by planar complexes of rhodium (I) |
| Q70439651 | Inhibition of cell division by sodium chloroiridate |
| Q41130062 | Inhibitory effects of a new oral gold compound on hela cells |
| Q72605126 | Inhibitory studies of DNA, RNA and protein synthesis in Escherichia coli by platinum containing complexes |
| Q40048032 | Interaction of Pt(II) complexes with DNAs from various sources. A circular dichroism study |
| Q41141577 | Interaction of cis-diamminedichloroplatinum(II) with phi X174 DNA. |
| Q52996234 | Interaction of cis-dichlorodiammineplatinum (II) with DNA |
| Q40764429 | Interaction of platinum compounds with bacterial DNA |
| Q67289035 | Interactions between tetrahydrofolate and palladium(II) complexes |
| Q34663069 | Interactions of platinum metals and their complexes in biological systems |
| Q51822028 | Investigation of the elasticity of a cisplatin-DNA adduct via single-molecule measurements and bimodal modeling. |
| Q39407436 | Investigational drugs under study by the United States National Cancer Institute |
| Q44069031 | Mass spectrometry of cis-diamminedichloroplatinum(II) adducts with the dinucleosidemonophosphates d(ApG), d(GpG) and d(TpC) in an ion trap. |
| Q38310005 | More pronounced salt dependence and higher reactivity for platination of the hairpin r(CGCGUUGUUCGCG) compared with d(CGCGTTGTTCGCG). |
| Q64033408 | Multiplicity of metal ion binding patterns to nucleobases |
| Q50166948 | Mutagenic activity of some platinum and palladium complexes |
| Q66894876 | Mutagenic properties of CIS-Platinum(II)diammino-dichloride in Escherichia coli |
| Q28241326 | Negative control of the Myc protein by the stress-responsive kinase Pak2 |
| Q39717597 | Noble Metal Complexes in Cancer Chemotherapy |
| Q28364232 | Nucleolar damage correlates with neurotoxicity induced by different platinum drugs |
| Q89687519 | Oncolytic adenovirus Ad11 enhances the chemotherapy effect of cisplatin on osteosarcoma cells by inhibiting autophagy |
| Q42461144 | Ototoxicity of cis-dichlorodiammine platinum (II) in guinea pigs |
| Q45111783 | Palladium(II) compounds with potential antitumour properties and their platinum analogues: a comparative study of the reaction of some orotic acid derivatives with DNA in vitro |
| Q69358010 | Phase I clinical trial of combined therapy with 5-FU (NSC 19893) and cis-platinum (II) diaminedichloride (NSC 119875) |
| Q67351775 | Physical studies on the binding of cis-dichlorodiamine platinum(II) to DNA and homopolynucleotides |
| Q50941553 | Platinosomes produced in synovial membrane by platinum coordination complexes |
| Q41582439 | Platinum complex-induced dysfunction of cultured renal proximal tubule cells. A comparative study of carboplatin and transplatin with cisplatin |
| Q67322645 | Platinum complexes of nucleotides |
| Q53728172 | Platinum coordination complexes in cancer chemotherapy. |
| Q67429352 | Post-replication repair of DNA in chinese hamster cells treated with CIS platinum (II) diamine dichloride. Enhancement of toxicity and chromosome damage by caffeine |
| Q64889081 | Preferential Interstrand Cross-Linking of DNA Rich in Guanine and Cytosine by cis-Dichlorodiammineplatinum(II) |
| Q33465444 | Preliminary clinical experience withcis-diamminedichloroplatinum (II) (NSC 119875, CACP) |
| Q34151556 | Preparation of organometallic ruthenium-arene-diaminotriazine complexes as binding agents to DNA. |
| Q38907617 | Quantitative analysis of Gd@C82(OH)22 and cisplatin uptake in single cells by inductively coupled plasma mass spectrometry. |
| Q33476310 | Rapid cross-linking of an RNA internal loop by the anticancer drug cisplatin |
| Q78045586 | Rapid fluorescence-based reporter-gene assays to evaluate the cytotoxicity and antitumor drug potential of platinum complexes |
| Q40472204 | Reactions of the UVRABC excision nuclease with DNA damaged by diamminedichloroplatinum(II). |
| Q38343385 | Reduced RNA synthesis levels in isolated mouse liver nuclei following reaction with [(H2O)(NH3)5Ru(II)]2+. |
| Q40308378 | Renaturation effects of cis and trans platinum II and IV compounds on calf thymus deoxyribonucleic acid |
| Q36458492 | Response of murine erythroleukemia cells to cis- and trans-diamminedichloroplatinum (II). |
| Q60585078 | Separation of platinated derivatives of nucleic acid bases on Sephadex G10 |
| Q37523234 | Sequence-dependent termination of in vitro DNA synthesis by cis- and trans-diamminedichloroplatinum (II). |
| Q59071343 | Specific binding of antitumour drug cis-Pt(NH3)2Cl2 to DNA rich in guanine and cytosine |
| Q72110388 | Study of the influence of phosphate groups on the formation of adenine nucleotide - cis-dichlorodiammineplatinum (II) complexes |
| Q72659524 | Synergistic effect ofcis-dichlorodiammineplatinum and 5-aza-2′-deoxycytidine on mouse leukemic cellsin vivo andin vitro |
| Q35116876 | The Chemical and Biological Effects of cis -Dichlorodiammineplatinum (II), an Antitumor Agent, on DNA |
| Q41150062 | The Mechanism of Action of Antitumor Platinum Compounds |
| Q54761524 | The effect of cis-dichlorodiammineplatinum(II) on Escherichia coli B the role of fil, exr and hcr markers |
| Q39929512 | The effect of heavy metal chelators on the renal accumulation of platinum after cis-dichlorodiammineplatinum II administration to the rat. |
| Q47729811 | The effects of boron containing peptides on L1210 lymphoid leukemia metabolism |
| Q69354003 | The effects of platinum ethylenediamine dichloride on the template activity of DNA |
| Q38356787 | The influence of Cisplatin on the gas-phase dissociation of oligonucleotides studied by electrospray ionization tandem mass spectrometry |
| Q40749663 | The interaction of an anti-tumour platinum complex with DNA |
| Q50217628 | The mutagenic effect of cis-diamminedichloroplatinum (II) and its degradation products in the Ames microbial assay |
| Q26999667 | The path for metal complexes to a DNA target |
| Q27729148 | The primary mode of binding of cisplatin to a B-DNA dodecamer: C-G-C-G-A-A-T-T-C-G-C-G |
| Q39933300 | Timed‐Release Depot for Anticancer Agents |
| Q39391487 | Tissue expression and correlation of a panel of urinary biomarkers following cisplatin-induced kidney injury |
| Q42415861 | Toxicity of platinum (IV) salts for cells of pulmonary origin |
| Q34071185 | Unusual DNA binding modes for metal anticancer complexes |
| Q67313471 | X-ray photoelectron spectroscopy of DNA · Pt complexes Evidence of O6(Gua) · N7(Gua) chelation of DNA with cis-dichlorodiamine platinum(II) |
| Q41646471 | [1,2-Bis(2-hydroxyphenyl)ethylenediamine]dichloroplatinum(II), a new compound for the therapy of ovarian cancer. III. Detailed evaluation of the antitumor activity of the enantiomeric complexes on the human NIH:OVCAR-3 ovarian cancer cell line |
| Q48705400 | alpha-Difluoromethylornithine-induced polyamine depletion of 9L tumor cells modifies drug-induced DNA cross-link formation |
| Q39805147 | cis-Diamminedichloroplatinum (II): A Metal Complex with Significant Anticancer Activity |
| Q67246961 | cis-Dichlorodiammineplatinum(II) (NSC-119 875): preclinical toxicologic evaluation of intravenous injection in dogs, monkeys and mice |
Search more.